ClinConnect ClinConnect Logo
Search / Trial NCT06598189

Ear-Seizure Detection (EarSD) Study

Launched by FELICIA CHU · Sep 13, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Seizure Detection Central Nervous System Diseases Nervous System Diseases

ClinConnect Summary

The Ear-Seizure Detection (EarSD) Study is a research project that aims to test a new wearable device designed to detect and predict seizures in people with epilepsy. This study will compare the device's accuracy to traditional methods of tracking seizures, which include video and brain wave recordings done in a hospital setting. Participants will wear this device while they are monitored in the Epilepsy Monitoring Unit at UMass Memorial Hospital.

To join this study, participants need to be at least 18 years old and currently undergoing long-term video-EEG monitoring for epilepsy. They should be willing to wear the device and be able to give their consent to participate. People who use other ear devices, have skin irritation where the device will be placed, or have certain medical conditions, such as being pregnant or having cognitive impairments, won't be eligible. Those who participate can expect to wear the device while their seizures are being observed, helping researchers learn how well this new technology works in real-time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥ 18 years.
  • 2. Patients admitted to UMass Memorial Epilepsy Monitoring Unit (EMU) for long term video-EEG monitoring as part of standard care of both focal and generalized epilepsy.
  • 3. Willing to wear the wearable device.
  • 4. Ability to provide informed consent
  • Exclusion Criteria:
  • 1. Subjects wearing other ear devices such as hearing aids.
  • 2. Inability or unwillingness to provide informed consent.
  • 3. Irritation of the skin where the device is to be placed.
  • 4. Patients with intracranial electrodes placement.
  • 5. Prisoners
  • 6. Cognitive impaired individuals
  • 7. Pregnant Women
  • 8. Children (Age 0-17)

About Felicia Chu

Felicia Chu is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, she focuses on innovative therapies and cutting-edge treatments across various therapeutic areas. Felicia emphasizes rigorous study design, regulatory compliance, and ethical standards, ensuring that all clinical trials are conducted with the utmost integrity and scientific rigor. Her leadership fosters collaboration among multidisciplinary teams, driving the successful execution of trials that contribute to the advancement of healthcare and the well-being of patients worldwide.

Locations

Worcester, Massachusetts, United States

Worcester, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Felicia Chu, MD

Principal Investigator

UMass Neurology Department

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported